{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:33:03Z","timestamp":1781105583639,"version":"3.54.1"},"reference-count":167,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.pcl.2006.08.004","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:28:34Z","timestamp":1168439314000},"page":"929-959","source":"Crossref","is-referenced-by-count":25,"title":["The Cell Biology of Acute Childhood Respiratory Disease: Therapeutic Implications"],"prefix":"10.1016","volume":"53","author":[{"given":"Gerald M.","family":"Loughlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Moscona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa025472","article-title":"Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children","volume":"350","author":"Williams","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2006.08.004_bib2","series-title":"Fields virology","first-page":"1205","article-title":"Parainfluenza viruses","author":"Collins","year":"1996"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The underrecognized burden of influenza in young children","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.285.5.535","article-title":"Burden of disease\u2013implications for future research","volume":"285","author":"Michaud","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.pcl.2006.08.004_bib5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/344310","article-title":"A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children","volume":"186","author":"Choi","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/345859","article-title":"Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms","volume":"187","author":"Hoebee","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/380908","article-title":"Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis","volume":"189","author":"Hoebee","year":"2004","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.pcl.2006.08.004_bib8","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1086\/429636","article-title":"Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis","volume":"191","author":"Wilson","year":"2005","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/321291","article-title":"Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus","volume":"69","author":"Hull","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00439-003-1038-x","article-title":"Haplotype mapping of the bronchiolitis susceptibility locus near IL8","volume":"114","author":"Hull","year":"2004","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/j.pcl.2006.08.004_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/377587","article-title":"Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus","volume":"188","author":"Hull","year":"2003","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.pcl.2006.08.004_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1203\/00006450-200206000-00006","article-title":"Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection","volume":"51","author":"Lahti","year":"2002","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/338473","article-title":"Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants","volume":"185","author":"Lofgren","year":"2002","journal-title":"J Infect Dis"},{"issue":"1 Pt 1","key":"10.1016\/j.pcl.2006.08.004_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.105.1.79","article-title":"Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease","volume":"105","author":"Ehlenfield","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/171.1.1","article-title":"Protective and disease-enhancing immune responses to respiratory syncytial virus","volume":"171","author":"Anderson","year":"1995","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1086\/517376","article-title":"Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults","volume":"177","author":"Falsey","year":"1998","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.pcl.2006.08.004_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00006454-200008000-00030","article-title":"Immunology of respiratory syncytial virus infection: eosinophils, cytokines, chemokines and asthma","volume":"19","author":"Welliver","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1096-9071(200010)62:2<257::AID-JMV19>3.0.CO;2-M","article-title":"Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB\/c mice","volume":"62","author":"van Schaik","year":"2000","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/1099-0496(200008)30:2<131::AID-PPUL8>3.0.CO;2-S","article-title":"Novel pathways in the pathogenesis of respiratory syncytial virus disease","volume":"30","author":"van Schaik","year":"2000","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/JVI.71.1.678-685.1997","article-title":"Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection","volume":"71","author":"Srikiatkhachorn","year":"1997","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1084\/jem.179.1.81","article-title":"Distinct types of lung disease caused by functional subsets of antiviral T cells","volume":"179","author":"Alwan","year":"1994","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/intimm\/4.4.493","article-title":"Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G","volume":"4","author":"Openshaw","year":"1992","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.168.3.1163","article-title":"Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus","volume":"168","author":"Cannon","year":"1988","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.pcl.2006.08.004_bib24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1086\/344644","article-title":"Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways","volume":"186","author":"Haeberle","year":"2002","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.pcl.2006.08.004_bib25","doi-asserted-by":"crossref","first-page":"10730","DOI":"10.1128\/JVI.75.22.10730-10737.2001","article-title":"Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus","volume":"75","author":"Haynes","year":"2001","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/80833","article-title":"Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus","volume":"1","author":"Kurt-Jones","year":"2000","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.pcl.2006.08.004_bib27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/infdis\/137.6.810","article-title":"Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans","volume":"137","author":"Scott","year":"1978","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib28","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4049\/jimmunol.133.4.1925","article-title":"Defective regulation of immune responses in respiratory syncytial virus infection","volume":"133","author":"Welliver","year":"1984","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2006.08.004_bib29","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0264-410X(01)00301-2","article-title":"Immunopathogenesis of vaccine-enhanced RSV disease","volume":"20","author":"Openshaw","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/322035","article-title":"Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity","volume":"184","author":"Bont","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1086\/322788","article-title":"Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis","volume":"184","author":"Garofalo","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"4 Pt 2","key":"10.1016\/j.pcl.2006.08.004_bib33","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S63","article-title":"Pathogenesis of respiratory syncytial virus vaccine-augmented pathology","volume":"152","author":"Graham","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.pcl.2006.08.004_bib34","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.66.12.7444-7451.1992","article-title":"Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of CD4+ T cells","volume":"66","author":"Connors","year":"1992","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib35","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JVI.70.5.2852-2860.1996","article-title":"Respiratory syncytial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern","volume":"70","author":"Waris","year":"1996","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.pcl.2006.08.004_bib36","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1128\/JVI.71.9.6935-6939.1997","article-title":"Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB\/c mice immunized with formalin-inactivated RSV","volume":"71","author":"Waris","year":"1997","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.pcl.2006.08.004_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"issue":"1 Suppl","key":"10.1016\/j.pcl.2006.08.004_bib38","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/01.inf.0000108194.71892.95","article-title":"The future of respiratory syncytial virus vaccine development","volume":"23","author":"Polack","year":"2004","journal-title":"Pediatr\u00a0Infect Dis J"},{"issue":"7","key":"10.1016\/j.pcl.2006.08.004_bib39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1086\/427998","article-title":"In search of a vaccine for respiratory syncytial virus: the saga continues","volume":"191","author":"Englund","year":"2005","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.pcl.2006.08.004_bib40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"Karron","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pcl.2006.08.004_bib41","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1073\/pnas.88.21.9663","article-title":"Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene","volume":"88","author":"Collins","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"10.1016\/j.pcl.2006.08.004_bib42","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.92.25.11563","volume":"92","author":"Collins","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1172\/JCI0216077","article-title":"Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics","volume":"110","author":"Murphy","year":"2002","journal-title":"J Clin Invest"},{"issue":"5\u20136","key":"10.1016\/j.pcl.2006.08.004_bib44","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0264-410X(01)00388-7","article-title":"Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines","volume":"20","author":"Simoes","year":"2001","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.pcl.2006.08.004_bib45","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.pcl.2006.08.004_bib46","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JVI.74.8.3455-3463.2000","article-title":"CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB\/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment","volume":"74","author":"Plotnicky-Gilquin","year":"2000","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.pcl.2006.08.004_bib47","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/324426","article-title":"Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults","volume":"184","author":"Power","year":"2001","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2003.12.006","article-title":"Current research on respiratory viral infections: Fifth International Symposium","volume":"62","author":"Ison","year":"2004","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib49","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1542\/peds.102.5.1211","article-title":"Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn","volume":"102","year":"1998","journal-title":"Pediatrics"},{"issue":"6 Pt 1","key":"10.1016\/j.pcl.2006.08.004_bib50","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1542\/peds.112.6.1447","article-title":"Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections","volume":"112","author":"Meissner","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jmb.2005.04.049","article-title":"Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization","volume":"350","author":"Wu","year":"2005","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1157\/13065284","article-title":"Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention","volume":"61","author":"Mejias","year":"2004","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.pcl.2006.08.004_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1993.1561","article-title":"Paramyxovirus fusion: a hypothesis for changes","volume":"197","author":"Lamb","year":"1993","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.pcl.2006.08.004_bib54","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/bi034385k","article-title":"Structural features of paramyxovirus F\u00a0protein required for fusion initiation","volume":"42","author":"Plemper","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.pcl.2006.08.004_bib55","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev.cellbio.12.1.627","article-title":"Virus-cell and cell-cell fusion","volume":"12","author":"Hernandez","year":"1996","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrm1076","article-title":"The structural biology of type I viral membrane fusion","volume":"4","author":"Colman","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.pcl.2006.08.004_bib57","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1128\/JVI.77.6.3647-3654.2003","article-title":"Triggering of human parainfluenza virus 3 fusion\u00a0protein(F) by the hemagglutinin-neuraminidase (HN): an HN mutation diminishing the rate of F activation and fusion","volume":"77","author":"Porotto","year":"2003","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.pcl.2006.08.004_bib58","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI25669","article-title":"Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease","volume":"115","author":"Moscona","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcl.2006.08.004_bib59","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/JVI.65.6.2773-2777.1991","article-title":"Fusion properties of cells persistently infected with human parainfluenza virus type 3: Participation of hemagglutinin-neuraminidase in membrane fusion","volume":"65","author":"Moscona","year":"1991","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.pcl.2006.08.004_bib60","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1128\/JVI.67.11.6463-6468.1993","article-title":"Relative affinity of the human parainfluenza virus 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity","volume":"67","author":"Moscona","year":"1993","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib61","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/JVI.79.4.2383-2392.2005","article-title":"Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein","volume":"79","author":"Porotto","year":"2005","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.pcl.2006.08.004_bib62","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/emboj\/20.15.4024","article-title":"Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion","volume":"20","author":"Russell","year":"2001","journal-title":"EMBO J"},{"issue":"21","key":"10.1016\/j.pcl.2006.08.004_bib63","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection","volume":"91","author":"Wild","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"10.1016\/j.pcl.2006.08.004_bib64","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1073\/pnas.89.21.10537","article-title":"A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition","volume":"89","author":"Wild","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1016\/j.pcl.2006.08.004_bib65","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.201392898","article-title":"Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region","volume":"98","author":"Eckert","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.pcl.2006.08.004_bib66","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1002\/j.1460-2075.1995.tb00239.x","article-title":"A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses","volume":"14","author":"Rapaport","year":"1995","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib67","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.93.5.2186","article-title":"Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion","volume":"93","author":"Lambert","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/viro.1996.0459","article-title":"Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection","volume":"223","author":"Yao","year":"1996","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1097-2765(00)80458-X","article-title":"Structural basis for paramyxovirus-mediated membrane fusion","volume":"3","author":"Baker","year":"1999","journal-title":"Mol Cell"},{"issue":"12","key":"10.1016\/j.pcl.2006.08.004_bib70","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nsb1295-1075","article-title":"A trimeric structural domain of the HIV-1 transmembrane glycoprotein","volume":"2","author":"Lu","year":"1995","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.pcl.2006.08.004_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00736-06","article-title":"Inhibition of Hendra virus membrane fusion","author":"Porotto","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.1998.9242","article-title":"A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41","volume":"248","author":"Joshi","year":"1998","journal-title":"Virology"},{"issue":"Pt 1","key":"10.1016\/j.pcl.2006.08.004_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/0022-1317-78-1-107","article-title":"Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein","volume":"78","author":"Wild","year":"1997","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/viro.1997.8834","article-title":"Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling","volume":"238","author":"Young","year":"1997","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.pcl.2006.08.004_bib75","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1128\/JVI.73.7.5945-5956.1999","article-title":"Interaction of peptides with sequences from the newcastle disease virus fusion protein heptad repeat regions","volume":"73","author":"Young","year":"1999","journal-title":"J Virol"},{"issue":"26","key":"10.1016\/j.pcl.2006.08.004_bib76","doi-asserted-by":"crossref","first-page":"15613","DOI":"10.1073\/pnas.95.26.15613","article-title":"Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target","volume":"95","author":"Chan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"10.1016\/j.pcl.2006.08.004_bib77","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1073\/pnas.0406696101","article-title":"Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion","volume":"101","author":"Cianci","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.423","article-title":"New drugs and treatment for respiratory syncytial virus","volume":"14","author":"Maggon","year":"2004","journal-title":"Rev Med Virol"},{"issue":"6 Suppl","key":"10.1016\/j.pcl.2006.08.004_bib79","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1203\/00006450-199006001-00011","article-title":"Control of pediatric viral diseases: past successes and future prospects","volume":"27","author":"Chanock","year":"1990","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib80","first-page":"391","article-title":"Current approaches to the development of vaccines effective against parainfluenza viruses","volume":"66","author":"Murphy","year":"1988","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.pcl.2006.08.004_bib81","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2006.08.004_bib82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jcp.23.1.7","article-title":"Pathological changes in virus infections of the lower respiratory tract in children","volume":"23","author":"Aherne","year":"1970","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.pcl.2006.08.004_bib83","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.1.5952.235","article-title":"Role of respiratory viruses in childhood mortality","volume":"1","author":"Downham","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.pcl.2006.08.004_bib84","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJM196611242752101","article-title":"Protective effect of antibody to parainfluenza type 1 virus","volume":"275","author":"Smith","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2006.08.004_bib85","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4049\/jimmunol.101.3.572","article-title":"Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2","volume":"101","author":"Tremonti","year":"1968","journal-title":"J Immunol"},{"key":"10.1016\/j.pcl.2006.08.004_bib86","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM199204023261404","article-title":"Parainfluenza virus respiratory infection after bone marrow transplantation","volume":"326","author":"Wendt","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2006.08.004_bib87","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/JVI.65.1.103-111.1991","article-title":"Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rat: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia","volume":"65","author":"Porter","year":"1991","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.pcl.2006.08.004_bib88","doi-asserted-by":"crossref","first-page":"12446","DOI":"10.1128\/JVI.75.24.12446-12451.2001","article-title":"Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo","volume":"75","author":"Prince","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.pcl.2006.08.004_bib89","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population","volume":"89","author":"Chin","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pcl.2006.08.004_bib90","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib91","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/381184","article-title":"Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6\u201318 months old","volume":"189","author":"Belshe","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib92","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.inf.0000066244.31769.83","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants","volume":"22","author":"Karron","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"13","key":"10.1016\/j.pcl.2006.08.004_bib93","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.vaccine.2005.12.002","article-title":"Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers","volume":"24","author":"Madhi","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.pcl.2006.08.004_bib94","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/428092","article-title":"A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy","volume":"191","author":"Greenberg","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib95","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/JVI.78.4.2017-2028.2004","article-title":"Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses","volume":"78","author":"Newman","year":"2004","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.pcl.2006.08.004_bib96","doi-asserted-by":"crossref","first-page":"11626","DOI":"10.1128\/JVI.74.24.11626-11635.2000","article-title":"Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector","volume":"74","author":"Haller","year":"2000","journal-title":"J Virol"},{"issue":"Pt 12","key":"10.1016\/j.pcl.2006.08.004_bib97","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1099\/vir.0.19522-0","article-title":"Evaluation of attenuation, immunogenicity and efficacy of a bovine parainfluenza virus type 3 (PIV-3) vaccine and a recombinant chimeric bovine\/human PIV-3 vaccine vector in rhesus monkeys","volume":"84","author":"Pennathur","year":"2003","journal-title":"J Gen Virol"},{"issue":"19","key":"10.1016\/j.pcl.2006.08.004_bib98","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1128\/JVI.74.19.8922-8929.2000","article-title":"Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates","volume":"74","author":"Schmidt","year":"2000","journal-title":"J Virol"},{"issue":"9427","key":"10.1016\/j.pcl.2006.08.004_bib99","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)16501-X","article-title":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS","volume":"363","author":"Bukreyev","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib100","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JVI.80.5.2267-2279.2006","article-title":"A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge","volume":"80","author":"Bukreyev","year":"2006","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.pcl.2006.08.004_bib101","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1086\/425981","article-title":"Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children","volume":"190","author":"Belshe","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.pcl.2006.08.004_bib102","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/infdis\/172.6.1445","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children","volume":"172","author":"Karron","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pcl.2006.08.004_bib103","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.1995.9925","article-title":"The hemagglutinin-neuraminidase of human parainfluenza virus type 3: role of the neuraminidase in the viral life cycle","volume":"214","author":"Huberman","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.pcl.2006.08.004_bib104","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/JVI.77.1.309-317.2003","article-title":"Mutations in human parainfluenza virus type 3 HN causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (zanamivir)","volume":"77","author":"Murrell","year":"2003","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib105","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jmb.2003.11.032","article-title":"Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III","volume":"335","author":"Lawrence","year":"2004","journal-title":"J Mol Biol"},{"issue":"24","key":"10.1016\/j.pcl.2006.08.004_bib106","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.1128\/JVI.78.24.13911-13919.2004","article-title":"Inhibition of parainfluenza type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites","volume":"78","author":"Porotto","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib107","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/JVI.80.3.1204-1213.2006","article-title":"Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site","volume":"80","author":"Porotto","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib108","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/AAC.49.1.398-405.2005","article-title":"The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae","volume":"49","author":"Alymova","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7072","key":"10.1016\/j.pcl.2006.08.004_bib109","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nature04322","article-title":"Structure of the parainfluenza virus 5 F protein in its metastable, perfusion conformation","volume":"439","author":"Yin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pcl.2006.08.004_bib110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2006.08.004_bib111","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1128\/JVI.75.16.7481-7488.2001","article-title":"Human parainfluenza virus type 3 HN-receptor interaction: the effect of 4-GU-DANA on a neuraminidase-deficient variant","volume":"76","author":"Porotto","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.pcl.2006.08.004_bib112","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/89098","article-title":"A newly discovered human pneumovirus isolated from young children with respiratory tract disease","volume":"7","author":"van den Hoogen","year":"2001","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.pcl.2006.08.004_bib113","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1086\/344319","article-title":"Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups","volume":"186","author":"Boivin","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib114","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/499274","article-title":"The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience","volume":"193","author":"Williams","year":"2006","journal-title":"J Infect Dis"},{"issue":"9343","key":"10.1016\/j.pcl.2006.08.004_bib115","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)11391-2","article-title":"Metapneumovirus and acute wheezing in children","volume":"360","author":"Jartti","year":"2002","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.pcl.2006.08.004_bib116","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1128\/JVI.78.13.6927-6937.2004","article-title":"The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness","volume":"78","author":"Skiadopoulos","year":"2004","journal-title":"J Virol"},{"issue":"Pt 6","key":"10.1016\/j.pcl.2006.08.004_bib117","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1099\/vir.0.79805-0","article-title":"Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design","volume":"85","author":"MacPhail","year":"2004","journal-title":"J Gen Virol"},{"issue":"17","key":"10.1016\/j.pcl.2006.08.004_bib118","doi-asserted-by":"crossref","first-page":"10944","DOI":"10.1128\/JVI.79.17.10944-10951.2005","article-title":"The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity","volume":"79","author":"Williams","year":"2005","journal-title":"J Virol"},{"issue":"Pt 12","key":"10.1016\/j.pcl.2006.08.004_bib119","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.pcl.2006.08.004_bib120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1258\/002367702320389026","article-title":"Diversifying animal models: the use of cotton rats (Sigmodon hispidus) in infectious diseases","volume":"36","author":"Niewiesk","year":"2002","journal-title":"Lab Anim"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib121","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.virol.2003.12.020","article-title":"Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes","volume":"321","author":"Biacchesi","year":"2004","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.pcl.2006.08.004_bib122","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.1128\/JVI.79.19.12608-12613.2005","article-title":"Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2\u20132 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates","volume":"79","author":"Biacchesi","year":"2005","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.pcl.2006.08.004_bib123","doi-asserted-by":"crossref","first-page":"15114","DOI":"10.1128\/JVI.79.24.15114-15122.2005","article-title":"Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo","volume":"79","author":"Pham","year":"2005","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.pcl.2006.08.004_bib124","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N Engl J Med"},{"issue":"5624","key":"10.1016\/j.pcl.2006.08.004_bib125","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.pcl.2006.08.004_bib126","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med"},{"issue":"6937","key":"10.1016\/j.pcl.2006.08.004_bib127","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/423240a","article-title":"Aetiology: Koch's postulates fulfilled for SARS virus","volume":"423","author":"Fouchier","year":"2003","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.pcl.2006.08.004_bib128","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1073\/pnas.0400762101","article-title":"A previously undescribed coronavirus associated with respiratory disease in humans","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib129","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"van der Hoek","year":"2004","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.pcl.2006.08.004_bib130","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1371\/journal.pmed.0020240","article-title":"Croup is associated with the novel coronavirus NL63","volume":"2","author":"van der Hoek","year":"2005","journal-title":"PLoS Med"},{"issue":"22","key":"10.1016\/j.pcl.2006.08.004_bib131","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.pcl.2006.08.004_bib132","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/AAC.01598-05","article-title":"Inhibition of human coronavirus NL63 infection at early stages of the replication cycle","volume":"50","author":"Pyrc","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pcl.2006.08.004_bib133","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0022-3476(63)80215-2","article-title":"The Treatment Of Bronchiolitis","volume":"63","author":"Reynolds","year":"1963","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib134","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","article-title":"Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7","volume":"161","author":"Sigurs","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"2 Suppl","key":"10.1016\/j.pcl.2006.08.004_bib136","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1067\/mpd.2003.19","article-title":"Viruses and asthma: inception, exacerbation, and possible prevention","volume":"142","author":"Lemanske","year":"2003","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib137","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0031-3955(03)00040-3","article-title":"Infectious triggers of pediatric asthma","volume":"50","author":"Gern","year":"2003","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.pcl.2006.08.004_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2006.04.008","article-title":"Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics","author":"Moore","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"2 Suppl","key":"10.1016\/j.pcl.2006.08.004_bib139","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/01.inf.0000053889.39392.a7","article-title":"Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma","volume":"22","author":"Martinez","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pcl.2006.08.004_bib140","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004878","article-title":"Glucocorticoids for acute viral bronchiolitis in infants and young children","volume":"3","author":"Patel","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcl.2006.08.004_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003123.pub2","article-title":"Epinephrine for bronchiolitis","volume":"1","author":"Hartling","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcl.2006.08.004_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001266.pub2","article-title":"Bronchodilators for bronchiolitis","volume":"3","author":"Gadomski","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib143","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ppul.1950010206","article-title":"Bronchodilator response during acute viral bronchiolitis in infancy","volume":"1","author":"Soto","year":"1985","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib144","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/08035250600554268","article-title":"Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis","volume":"95","author":"Kim","year":"2006","journal-title":"Acta Paediatr"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ppul.20285","article-title":"Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy","volume":"40","author":"Piedimonte","year":"2005","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib146","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/rccm.200207-747OC","article-title":"A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis","volume":"167","author":"Bisgaard","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib147","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1164\/rccm.2211006","article-title":"Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings?","volume":"167","author":"Szefler","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib148","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1378\/chest.120.1.203","article-title":"Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis","volume":"120","author":"Nasr","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib149","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1183\/09031936.01.18040734","article-title":"DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis","volume":"18","author":"Merkus","year":"2001","journal-title":"Eur Respir J"},{"issue":"4 Pt 1","key":"10.1016\/j.pcl.2006.08.004_bib150","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1164\/ajrccm.159.4.9709065","article-title":"Surfactant protein levels in severe respiratory syncytial virus infection","volume":"159","author":"Kerr","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.pcl.2006.08.004_bib151","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI5849","article-title":"Surfactant protein-A enhances respiratory syncytial virus clearance in vivo","volume":"103","author":"LeVine","year":"1999","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib152","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1165\/rcmb.2003-0107OC","article-title":"Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus","volume":"31","author":"LeVine","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4 Pt 1","key":"10.1016\/j.pcl.2006.08.004_bib153","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/ajrccm.162.4.9909004","article-title":"Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis","volume":"162","author":"Tibby","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcl.2006.08.004_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005150.pub2","article-title":"Surfactant therapy for bronchiolitis in critically ill infants","volume":"3","author":"Ventre","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"1 Suppl","key":"10.1016\/j.pcl.2006.08.004_bib155","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.inf.0000108187.63151.ea","article-title":"Advances in the laboratory diagnosis of viral respiratory disease","volume":"23","author":"Henrickson","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib156","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3928\/0090-4481-20050101-08","article-title":"Cost-effective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections","volume":"34","author":"Henrickson","year":"2005","journal-title":"Pediatr Ann"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib157","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcv.2003.10.003","article-title":"Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens","volume":"30","author":"Puppe","year":"2004","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib158","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3201\/eid1102.040492","article-title":"Diagnostic system for rapid and sensitive differential detection of pathogens","volume":"11","author":"Briese","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.pcl.2006.08.004_bib159","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/JCM.39.5.1696-1701.2001","article-title":"Evaluation of the Hexaplex assay for detection of respiratory viruses in children","volume":"39","author":"Kehl","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.pcl.2006.08.004_bib160","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/516357","volume":"26","author":"Fan","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.pcl.2006.08.004_bib161","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/JCM.34.8.1914-1917.1996","article-title":"Rapid diagnosis of human parainfluenza virus type 1 infection by quantitative reverse transcription-PCR-enzyme hybridization assay","volume":"34","author":"Fan","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.pcl.2006.08.004_bib162","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jcv.2004.11.023","article-title":"Detection and quantification of human metapneumovirus in pediatric specimens by real-time RT-PCR","volume":"33","author":"Kuypers","year":"2005","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.pcl.2006.08.004_bib163","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/JCM.42.3.981-986.2004","article-title":"Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages","volume":"42","author":"Maertzdorf","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib164","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/JCM.41.1.100-105.2003","article-title":"Molecular assays for detection of human metapneumovirus","volume":"41","author":"Mackay","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.pcl.2006.08.004_bib165","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1128\/JCM.41.8.3631-3635.2003","article-title":"Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus","volume":"41","author":"Cote","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.pcl.2006.08.004_bib166","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2334-5-6","article-title":"A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium","volume":"5","author":"Moes","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.pcl.2006.08.004_bib167","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-1702(99)00017-9","article-title":"Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay","volume":"60","author":"Stephensen","year":"1999","journal-title":"Virus Res"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395506000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395506000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T09:42:10Z","timestamp":1683711730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395506000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":167,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0031395506000964"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2006.08.004","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}